Daniel Ryan

2.0k total citations
43 papers, 1.4k citations indexed

About

Daniel Ryan is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Daniel Ryan has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Daniel Ryan's work include Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Immune Cell Function and Interaction (5 papers). Daniel Ryan is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Immune Cell Function and Interaction (5 papers). Daniel Ryan collaborates with scholars based in United States, Sweden and Ireland. Daniel Ryan's co-authors include Richard A. Insel, Iñaki Sanz, Gregg J. Silverman, Aimee E. Pugh‐Bernard, Amedeo Cappione, Camille N. Abboud, B L Nuccie, Jane L. Liesveld, Harvey J. Cohen and Barbara L. Asselin and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel Ryan

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ryan United States 16 564 424 263 255 199 43 1.4k
James T. Rosenbaum United States 29 701 1.2× 151 0.4× 119 0.5× 472 1.9× 173 0.9× 63 2.2k
Dwight Naime United States 8 348 0.6× 217 0.5× 96 0.4× 306 1.2× 156 0.8× 8 1.3k
Richard F. Olsson Sweden 26 317 0.6× 692 1.6× 183 0.7× 257 1.0× 214 1.1× 55 1.8k
Damini Jawaheer United States 18 574 1.0× 128 0.3× 183 0.7× 143 0.6× 181 0.9× 35 1.6k
Jenny Chia Australia 14 284 0.5× 285 0.7× 79 0.3× 257 1.0× 100 0.5× 21 1.2k
Cindy Jacobs United States 20 495 0.9× 215 0.5× 57 0.2× 401 1.6× 38 0.2× 58 1.5k
Toby Garrood United Kingdom 14 420 0.7× 287 0.7× 61 0.2× 133 0.5× 48 0.2× 36 1.1k
O. Petter Veiby Norway 19 612 1.1× 522 1.2× 147 0.6× 351 1.4× 45 0.2× 35 1.3k
Y Kanakura Japan 15 392 0.7× 355 0.8× 187 0.7× 306 1.2× 34 0.2× 32 922
Е. Р. Черных Russia 18 521 0.9× 112 0.3× 200 0.8× 281 1.1× 65 0.3× 161 1.2k

Countries citing papers authored by Daniel Ryan

Since Specialization
Citations

This map shows the geographic impact of Daniel Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ryan more than expected).

Fields of papers citing papers by Daniel Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ryan. The network helps show where Daniel Ryan may publish in the future.

Co-authorship network of co-authors of Daniel Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ryan. A scholar is included among the top collaborators of Daniel Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ryan. Daniel Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Daniel, et al.. (2025). Prognostic factors of Mucoepidermoid Carcinoma within the head and neck: A NCDB analysis. Cancer Epidemiology. 99. 102945–102945.
2.
Ryan, Daniel, Saeedeh Mirbagheri, & Noushin Yahyavi‐Firouz‐Abadi. (2023). The Current State of Functional MR Imaging for Trauma Prognostication. Neuroimaging Clinics of North America. 33(2). 299–313. 1 indexed citations
3.
Gujar, Sachin K., Daniel Ryan, Shruti Agarwal, et al.. (2023). Identification of the Language Network from Resting-State fMRI in Patients with Brain Tumors: How Accurate Are Experts?. American Journal of Neuroradiology. 44(3). 274–282. 6 indexed citations
4.
Ryan, Daniel, et al.. (2022). Occupational Therapists’ Perspectives on Caregiver Education of Stroke Survivors. SHILAP Revista de lepidopterología. 10(1). 1–16. 3 indexed citations
5.
Cortes, Jörge E., Donna E. Hogge, Scott R. Solomon, et al.. (2021). Five-Year Final Results of a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukemia (AML): Outcomes By Age Subgroup and Among Responders. Transplantation and Cellular Therapy. 27(3). S126–S127. 3 indexed citations
6.
Jalilianhasanpour, Rozita, Daniel Ryan, Licia Luna, et al.. (2021). Role of Functional Magnetic Resonance Imaging in the Presurgical Mapping of Brain Tumors. Radiologic Clinics of North America. 59(3). 377–393. 5 indexed citations
7.
Jalilianhasanpour, Rozita, Daniel Ryan, Shruti Agarwal, et al.. (2020). Dynamic Brain Connectivity in Resting State Functional MR Imaging. Neuroimaging Clinics of North America. 31(1). 81–92. 16 indexed citations
8.
Ryan, Daniel, Laura F. Newell, Ellen K. Ritchie, et al.. (2020). Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis. Biology of Blood and Marrow Transplantation. 26(3). S9–S10. 1 indexed citations
9.
Ryan, Daniel, Laura F. Newell, Ellen K. Ritchie, et al.. (2019). Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis. Blood. 134(Supplement_1). 3842–3842. 1 indexed citations
10.
Ryan, Daniel, et al.. (2019). Effects of 5-ALA dose on resection of glioblastoma. Journal of Neuro-Oncology. 141(3). 523–531. 24 indexed citations
11.
Patel, Amit, et al.. (2018). Patient counseling materials: The effect of patient health literacy on the comprehension of printed prescription drug information. Research in Social and Administrative Pharmacy. 14(9). 851–862. 10 indexed citations
12.
13.
Ryan, Daniel & Carol A. Bauer. (2016). Neuroscience of Tinnitus. Neuroimaging Clinics of North America. 26(2). 187–196. 29 indexed citations
14.
Phatak, Pradyumna D., Daniel Ryan, Joseph D. Cappuccio, et al.. (2002). Prevalence and Penetrance of HFE Mutations in 4865 Unselected Primary Care Patients. Blood Cells Molecules and Diseases. 29(1). 41–47. 48 indexed citations
15.
Pugh‐Bernard, Aimee E., Gregg J. Silverman, Amedeo Cappione, et al.. (2001). Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. Journal of Clinical Investigation. 108(7). 1061–1070. 261 indexed citations
16.
Pugh‐Bernard, Aimee E., Gregg J. Silverman, Amedeo Cappione, et al.. (2001). Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. Journal of Clinical Investigation. 108(7). 1061–1070. 250 indexed citations
17.
Ryan, Daniel, et al.. (1997). Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. The Journal of Immunology. 159(3). 1068–1071. 75 indexed citations
18.
Rowe, Jacob M., Daniel Ryan, John F. DiPersio, et al.. (1993). Allografting in chronic myelogenous leukemia followed by immunotherapy. Stem Cells. 11(S3). 34–42. 13 indexed citations
19.
Ryan, Daniel, B L Nuccie, & Camille N. Abboud. (1992). Inhibition of human bone marrow lymphoid progenitor colonies by antibodies to VLA integrins. The Journal of Immunology. 149(11). 3759–3764. 51 indexed citations
20.
Asselin, Barbara L., Daniel Ryan, Christopher Frantz, et al.. (1989). In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase.. PubMed. 49(15). 4363–8. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James T. Rosenbaum Breakdown of academic impact, for papers by Dwight Naime Breakdown of academic impact, for papers by Richard F. Olsson Breakdown of academic impact, for papers by Damini Jawaheer Breakdown of academic impact, for papers by Jenny Chia Breakdown of academic impact, for papers by Cindy Jacobs Breakdown of academic impact, for papers by Toby Garrood Breakdown of academic impact, for papers by O. Petter Veiby Breakdown of academic impact, for papers by Y Kanakura Breakdown of academic impact, for papers by Е. Р. Черных
Rankless by CCL
2026